Transrectal prostate ultrasound

from Wikipedia, the free encyclopedia
A schematic picture of the use of the probe

The transrectal ultrasonography (abbreviated as TPS or TRUS for transrectal ultrasound ) is a diagnostic imaging method , in which with the aid of ultrasound a photograph of the internal organs in the pelvic region is made.

nomenclature

The precise name is transrectal prostate ultrasonography and is abbreviated as TPS . Colloquially, this procedure is also less precisely referred to as transrectal ultrasound , which is abbreviated as TRUS . In English the same abbreviation TRUS is used, there for transrectal ultrasonography .

Procedure

This procedure belongs to the class of sonographies . At first it was mainly used for the early detection of diseases of the prostate such as benign prostatic hyperplasia or prostate cancer . Since prostate cancer screening has also been done with the help of the determination of the PSA value , transrectal prostate ultrasound is mainly used for precise control during a biopsy of tissue from the prostate.

A probe is inserted into the anus and placed inside the intestine near the prostate. The proximity of the prostate to the intestinal wall enables particularly good images.

If transrectal ultrasound is used for the early detection of prostate cancer, it is a so-called individual health service in Germany and does not have to be paid for by the statutory health insurance companies. The IGeL Monitor of the Medical Service Association of the National Association of Health Insurance Funds rated this service as "generally negative". The reason: No studies were found in the systematic analysis of the literature that investigated the benefits and harm of ultrasound for early detection of prostate cancer. Above all, palpation, PSA tests and ultrasound are offered for early detection. Scanning is a cash benefit. PSA tests and ultrasound are only covered by statutory health insurances if cancer is suspected or if there are complaints that suggest prostate cancer.

Individual evidence

  1. a b Hubert E. Weiss: Transrectal Ultrasound (TRUS). (No longer available online.) Takeda Pharma GmbH, June 8, 2006, archived from the original on January 6, 2012 ; Retrieved February 4, 2012 . Info: The archive link was inserted automatically and has not yet been checked. Please check the original and archive link according to the instructions and then remove this notice. @1@ 2Template: Webachiv / IABot / www.prostata.de
  2. ^ PM O'Donoghue, SE McSweeney, K Jhaveri: Genitourinary imaging: current and emerging applications . In: J Postgrad Med . tape 56 , no. 2 , 2010, p. 131-139 , doi : 10.4103 / 0022-3859.65291 , PMID 20622393 (English, jpgmonline.com ).
  3. IGeL-Monitor, ultrasound for the early detection of prostate cancer , accessed on October 25, 2018.
  4. Federal Ministry of Health, Cancer Early Detection, Statutory Health Insurance Benefits , accessed on November 6, 2018.